期刊
CHEMMEDCHEM
卷 16, 期 5, 页码 743-766出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.202000695
关键词
AIDS; HIV-1; NRTI; nucleoside analogues; reverse transcriptase inhibitors
资金
- AMED [JP20fk0310102, JP20am0401008, JP20ak0101119]
- JST-CREST [JPMJCR18S1]
- Takeda Science Foundation
Despite the availability of various anti-HIV drugs, NRTIs remain widely used and of interest. However, HIV has developed resistance against NRTIs, necessitating the search for novel therapies to combat the virus.
Acquired immunodeficiency syndrome (AIDS) is caused by infection with the human immunodeficiency virus (HIV). Although treatments against HIV infection are available, AIDS remains a serious disease that causes many deaths annually. Although a variety of anti-HIV drugs have been synthesized and marketed to treat HIV-infected patients, nucleoside analogue reverse transcriptase inhibitors (NRTIs), which mimic nucleosides, are used extensively and remain a subject of interest to medicinal chemists. However, HIV has acquired drug resistance against NRTIs, and thus the struggle to find novel therapies continues. In this review, we trace the trajectory of NRTIs, focusing on the synthesis, mechanisms of action and applications of NRTIs that have been developed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据